The Food and Drug Administration will hold meetings this summer to discuss whether compounding pharmacies should be allowed to manufacture half a dozen commonly sought, yet unproven peptides. Health Secretary Robert F. Kennedy Jr. claims the move will help shut down the black market for these products.
Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice.
Or get in touch at support@businessoffashion.com
if you experience difficulties.
